Skip to main content
PolyPeptide Group AG logo

PolyPeptide Group AG — Investor Relations & Filings

Ticker · PPGN ISIN · CH1110760852 LEI · 5067007JCKTPOX4G9758 SW Manufacturing
Open in API
Filings indexed 111 across all filing types
Latest filing 2026-04-14 Regulatory Filings
Country CH Switzerland
Listing SW PPGN

About PolyPeptide Group AG

https://www.polypeptide.com/

PolyPeptide Group AG is a Contract Development & Manufacturing Organization (CDMO) specializing in peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). The company serves the pharmaceutical and biotech sectors by providing a comprehensive range of services that cover all stages of product development, from pre-clinical to commercial manufacturing. Its offerings include both proprietary (custom) and generic GMP-grade peptides. PolyPeptide focuses on innovation in peptide synthesis and manufacturing processes to support the development of therapies for patients.

Recent filings

Filing Released Lang Actions
PolyPeptide Group AG takes note of market rumors and speculation
Regulatory Filings Classification · 90% confidence The document is an ad hoc market disclosure under Art. 53 LR by a Swiss‐listed issuer reacting to takeover rumors. It contains no financial results, no board or management changes, no voting details, no dividend or share transactions, and no actual M&A or capital transaction being announced—only acknowledgement of speculation. This falls into the general regulatory announcements category (RNS) as a fallback for miscellaneous filings.
2026-04-14 English
PolyPeptide Group AG takes note of market rumors and speculation
Regulatory Filings Classification · 85% confidence The document is an ad hoc media release pursuant to Art. 53 of the SIX Swiss Exchange Listing Rules, providing inside information about market rumours of takeover interest and noting a strategic review. It is not a formal takeover bid announcement, detailed M&A transaction document, or financial report; rather it is a regulatory announcement/disclosure. Therefore it best fits the general “Regulatory Filings” category (RNS).
2026-04-14 English
PolyPeptide announces results of the annual General Meeting 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a media release announcing the results of the company’s Annual General Meeting 2026, detailing share votes represented and the approval of board re-elections and other proposals. This is a declaration of voting results from an AGM, fitting the ‘Declaration of Voting Results & Voting Rights Announcements’ category.
2026-04-08 English
PolyPeptide announces results of the annual General Meeting 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a media release announcing the shareholders’ vote outcomes at the annual General Meeting 2026, detailing which proposals were approved and the vote statistics. This corresponds to a Declaration of Voting Results & Voting Rights Announcement, not the full AGM materials or minutes.
2026-04-08 English
PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2026 bekannt
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a media release announcing the detailed results of the 2026 Ordinary General Meeting (AGM), including vote counts and resolutions passed. It does not present the AGM materials themselves but reports on the outcome of shareholder votes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-08 German
PolyPeptide strengthens financing structure through expansion of existing credit facility
Capital/Financing Update Classification · 100% confidence The document is a media release announcing the expansion of a credit facility for PolyPeptide Group. It details the financial arrangement, the lending syndicate involved, and the strategic purpose of the financing. This falls directly under the definition of a capital or financing update, as it concerns the company's capital structure and debt facilities.
2026-03-19 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.